Common use of Underwriter’s Warrant Clause in Contracts

Underwriter’s Warrant. The Company hereby agrees to issue to the Underwriter (and/or its designees) on a Closing Date, as defined in Section 3(c) herein, a warrant to purchase a number of Ordinary Shares equal to 5% of the gross proceeds on a Closing Date for the Underwritten Shares divided by the Purchase Price (“Underwriter’s Warrant”). The Underwriter’s Warrant, in the form attached hereto as Exhibit A, shall be exercisable, in whole or in part, commencing on the date of issuance on the Effective Date (as defined below) and expiring on the five-year anniversary from the Closing Date at an initial exercise price equal to the Per Share Price (as defined below) of the Underwritten Shares. The Underwriter’s Warrant shall include a “cashless” exercise feature. The Underwriter understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Underwriter’s Warrant and the underlying Ordinary Shares during the one hundred eighty (180) days after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Underwriter’s Warrant, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the Effective Date to anyone other than the circumstances listed under FINRA Rule 5110(g)(2). Delivery of the Underwriter’s Warrant shall be made on a Closing Date and shall be issued in the name or names and in such authorized denominations as the Underwriter may request.

Underwriter’s Warrant. The Company hereby agrees to issue to the Underwriter (and/or its designees) on a Closing Date, as defined in Section 3(c) herein, a warrant to purchase a number of Ordinary Shares equal to 5% seven percent (7%) of the gross proceeds Ordinary Shares sold on a such Closing Date for the Underwritten Shares divided by the Purchase Price (“Underwriter’s Warrant”). The Underwriter’s Warrant, in the form attached hereto as Exhibit A, shall be exercisable, in whole or in part, commencing on the date of issuance on the Effective Date (as defined below) and expiring on the five-year anniversary from the Closing Date date that the Commission (as defined herein) declared the Registration Statement (as defined herein) effective (the “Effective Date”) at an initial exercise price equal to 110% of the Per Share Price (as defined below) of the Underwritten SharesSecurities. The Underwriter’s Warrant shall include a “cashless” exercise feature. The Underwriter understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Underwriter’s Warrant and the underlying Ordinary Shares during the one hundred eighty (180) days after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Underwriter’s Warrant, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the Effective Date to anyone other than the circumstances listed under FINRA Rule 5110(g)(2). Delivery of the Underwriter’s Warrant shall be made on a Closing Date and shall be issued in the name or names and in such authorized denominations as the Underwriter may request.

Underwriter’s Warrant. The Company hereby agrees to issue to the Underwriter (and/or its designees) on a Closing Date, as defined in Section 3(c) herein, a warrant to purchase a number of Ordinary Shares equal to 5% seven percent (7%) of the gross proceeds Ordinary Shares sold on a such Closing Date for the Underwritten Shares divided by the Purchase Price (“Underwriter’s Warrant”). The Underwriter’s Warrant, in the form attached hereto as Exhibit A, shall be exercisable, in whole or in part, commencing on the date of issuance on the Effective Date (as defined below) and expiring on the five-year anniversary from the Closing Date date that the Commission (as defined herein) declared the Registration Statement (as defined herein) effective (the “Effective Date”) at an initial exercise price equal to the Per Share Price (as defined below) of the Underwritten SharesSecurities. The Underwriter’s Warrant shall include a “cashless” exercise feature. The Underwriter understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Underwriter’s Warrant and the underlying Ordinary Shares during the one hundred eighty (180) days after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Underwriter’s Warrant, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the Effective Date to anyone other than the circumstances listed under FINRA Rule 5110(g)(2). Delivery of the Underwriter’s Warrant shall be made on a Closing Date and shall be issued in the name or names and in such authorized denominations as the Underwriter may request.

Underwriter’s Warrant. The Company hereby agrees to issue to the Underwriter (and/or its designees) on a the Closing Date, as defined in Section 3(c) herein, Date a warrant to (“Underwriter’s Warrant”) for the purchase of a number of Ordinary Shares ADSs equal to 5% of the gross proceeds on a Closing Date for aggregate number of ADSs sold in the Underwritten Shares divided by the Purchase Price (“Underwriter’s Warrant”)offering. The Underwriter’s Warrant, Warrant in the form attached hereto as Exhibit A, A shall be exercisable, in whole or in part, during a period commencing on a date that is six months after the date of issuance on the Effective Closing Date (as defined below) and expiring on the fivethree-year anniversary from of the Closing Date at an initial exercise price per ADS of $8.75, which is equal to the Per Share Price (as defined below) 125% of the Underwritten SharesPublic Offering Price of the ADSs. The Underwriter’s Warrant shall include a and the ADSs issuable upon exercise thereof are sometimes hereinafter referred to collectively as the “cashlessUnderwriter’s Securities.” exercise feature. The Underwriter understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Underwriter’s Warrant and the underlying Ordinary Shares ADSs during 180 days following the one hundred eighty (180) days after date of effectiveness or commencement of sales of the Effective Date public offering and by its acceptance thereof shall agree that it will not not, sell, transfer, assign, pledge or hypothecate the Underwriter’s Warrant, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period beginning on the date of one hundred eighty effectiveness of the Registration Statement (180the “Effective Date”) until 180 days following after the Effective Closing Date to anyone other than (i) an Underwriter or a selected dealer in connection with the circumstances listed under FINRA Rule 5110(g)(2). Delivery Offering, or (ii) a bona fide officer or partner of the Underwriter’s Warrant shall be made on a Closing Date Underwriter or of any such Underwriter or selected dealer; and shall be issued in only if any such transferee agrees to the name or names and in such authorized denominations as the Underwriter may requestforegoing lock-up restrictions.